Model for end-stage liver disease: New basis of allocation for liver transplantations;Model for End-stage Liver Disease : Neue Grundlage der Allokation für die Lebertransplantation

Chirurg

Volumn 79, Issue 2, 2008, Pages 157-163

  Jung, G E ^a   Encke, J ^a   Schmidt, J ^a   Rahmel, A ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b EUROTRANSPLANT INTERNATIONAL FOUNDATION   (Netherlands)

Author keywords

Allocation; Eurotransplant; Liver transplant; Model for end stage liver disease

Indexed keywords

BILIRUBIN; CREATININE;

ARTICLE; BLOOD; DONOR; EUROPE; GERMANY; HEALTH STATUS; HOSPITAL ADMISSION; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER FAILURE; LIVER TUMOR; MORTALITY; NEEDS ASSESSMENT; POSTOPERATIVE COMPLICATION; PROTHROMBIN TIME; RISK FACTOR; STATISTICS; SURVIVAL RATE;

BILIRUBIN; CREATININE; EUROPE; GERMANY; HEALTH STATUS; HUMANS; INTERNATIONAL NORMALIZED RATIO; LIVER FAILURE; LIVER NEOPLASMS; NEEDS ASSESSMENT; POSTOPERATIVE COMPLICATIONS; PROTHROMBIN TIME; RISK FACTORS; SURVIVAL RATE; TISSUE DONORS; WAITING LISTS;

EID: 39149141006     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00104-008-1463-4     Document Type: Article

References (22)

1. Austin MT, Poulose BK, Ray WA et al. (2007) Model for end-stage liver disease: did the new liver allocation policy affect waiting list mortality? Arch Surg 142: 1079-1085
2. Biggins SW, Bambha K (2006) MELD-based liver allocation: who is underserved? Semin Liver Dis 26: 211-220
3. Cholongitas E, Shusang V, Marelli L et al. (2007) Review article: renal function assessment in cirrhosis - difficulties and alternative measurements. Aliment Pharmacol Ther 26: 969-978
4. Cholongitas E, Marelli L, Shusang V et al. (2006) A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation. Liver Transplantation 12:1049-1061
5. Freeman RB, Wiesner RH, Edwards E et al. United Network for Organ Sharing Organ Procurement and Transplantation Network Liver and Transplantation Committee (2004) Results of the first year of the liver allocation plan. Liver Transpl 10: 7-15
6. Freeman RB, Harper A, Edwards EB (2005) Excellent liver transplant survival rates under the MELD/PELD system. Transplant Proc 37: 585-588
7. Heumann D, Mihas A (2003) Utility of the MELD score for assessing 3-month survival in patients with liver cirrhosis: One more positive answer. Gastroenterology 125: 992-993
8. Huo TI, Wu JC, Lin HC et al. (2005) Evaluation of the increase in model for end-stage liver disease (Delta MELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score. J Hepatol 42: 826-832
9. Renz JF, Kin C, Kinkhabwala M et al. (2005) Utilization of extended donor criteria liver allografts maximizes donor use and patient access to liver transplantation. Ann Surg 242: 556-565
10. Kamath PS, Wiesner RH, Malinchoc M et al. (2001) A model to predict survival in patients with end-stage liver disease. Hepatology 33: 464-470
11. Lopez PM, Martin P (2006) Update on liver transplantation: indications, organ allocation, and long-term care. Mt Sinai J Med 73: 1056-1066
12. Malinchoc M, Kamath PS, Gordon FD et al. (2000) A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31: 864-871
13. Austin MT, Poulose MK, Ray WA et al. (2007) Model for end-stage liver disease. Arch Surg 142: 1079-1085
14. Lopez PM, Martin P (2006) Update on liver transplantation. Mt Sinai J Med 73: 1056-1066
15. Pugh R, Murray-Lyon I, Dawson J (1973) Transsection of the oesophagus for bleding oesophageal varices. Br J Surg 60: 646-649
16. Brown RS Jr, Russo MW, Lai M et al. (2003) A survey of liver transplantation from living adult donors in the United States. New England J Med 348: 818-825
17. Trotter JF, Brimhall B, Arjal R, Phillips C (2004) Specific laboratory methodologies achieve higher model for endstage liver disease (MELD) scores for patients listed for liver transplantation. Liver Transpl 10: 995-1000
18. Trotter JF, Olson J, Lefkowitz J et al. (2007) Changes in international normalized ratio (INR) and model for endstage liver disease (MELD) based on selection of clinical laboratory. AM J Transplant 7: 1624-1628
19. Wiesner RH, McDiarmid SV, Kamath PS et al. (2001) MELD and PELD: application of survival models to liver allocation. Liver Transpl 7: 567-580
20. Wiesner R, Edwards E, Kamath P (2001) Mayo end-stage liver disease model (MELD) score predicts liver transplant waiting list mortality: Implications for liver allocation policy. Transplantation [Suppl 1] 71: 461
21. Wiesner R, Edwards E, Freeman R et al. (2003) Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 124: 91-96
22. Verdonk RC, Berg AP van den, Slooff MJ et al. (2007) Liver transplantation: an update. Neth J Med 65: 372-380